KGET OTC
CaliPharms, Inc.
1W: +3900.0%
1M: +0.0%
3M: +0.0%
YTD: +3900.0%
1Y: +3900.0%
3Y: +3900.0%
5Y: -80.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$12K
+0.0% ▲
Gross Profit
$12K
+0.0% ▲
Operating Income
-$1M
-276.3% ▼
Net Income
-$1M
-222.3% ▼
EPS (Diluted)
$-0.00
+0.0% ▲
EBITDA
-$1M
-276.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2013 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $12K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $12K |
| Gross Margin | — | — | — | 100.0% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $184K | $340K | $358K | $1M |
| Operating Expenses | $184K | $340K | $358K | $1M |
| Operating Income | -$184K | -$340K | -$358K | -$1M |
| Operating Margin | — | — | — | -11222.7% |
| Interest Expense | $145K | $618K | $84K | $77K |
| Income Before Tax | -$213K | -$959K | -$442K | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$213K | -$959K | -$442K | -$1M |
| Net Margin | — | — | — | -11861.4% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$184K | -$340K | -$358K | -$1M |
| Shares Outstanding | 2.26B | 6.35B | 6.46B | 10.78B |